Untitled

Paterson, Charlotte; Langan, Charles E.; McKaig, G.A.; Anderson, Pippa; Maclaine, Grant; Rose, L.; Walker, Sara J.; Campbell, Mike

doi:10.1023/a:1008930521566

Cited by 75 publications

(18 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results for the disease-targeted measures administered in this study were similar to those previously reported [5-8]. The magnitude of score differences between stable and exacerbating patients for the disease-specific measures is substantially greater than for the PROMIS measures.…”

Section: Discussionsupporting

confidence: 88%

“…Several studies have now confirmed that COPD patients experiencing an exacerbation report significantly poorer HRQOL than stable COPD patients using either generic or disease-targeted measures [5-8]. The results for the disease-targeted measures administered in this study were similar to those previously reported [5-8].…”

Section: Discussionsupporting

confidence: 86%

“…Most COPD specific measures correlate weakly with clinical measures such as FEV1 [32-35, 37]. Therefore, the best instrument and the relative sensitivity of generic versus condition-targeted measures is not generally agreed upon in the literature [5-8]. Since PROMIS instruments are designed to be applicable to a range of chronic illnesses, they allow for comparisons across a variety of chronic health conditions and studies.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations

et al. 2014

View full text Add to dashboard Cite

Purpose The Patient-Reported Outcomes Measurement Information System (PROMIS®) initiative was developed to advance the methodology of PROs applicable to chronic diseases. Chronic obstructive pulmonary disease (COPD) is a progressive chronic disease associated with poor health. This study was designed to examine the correlation of PROMIS health-related quality of life (HRQOL) scales and clinical measures among COPD patients. Methods A cross-sectional analysis was conducted comparing patients who were stable (n = 100) with those currently experiencing a COPD exacerbation (n=85). All PROMIS measures for adults available at the time of the study (2008), disease-targeted and other HRQOL instruments, health literacy, percent predicted FEV1, and a 6-minute walk distance were assessed when patients were considered clinically stable. Results Stable COPD patients reported significantly (p≤0.05) better health-related quality of life on PROMIS domains than patients experiencing an exacerbation. PROMIS domain scores were significantly (p≤0.01) correlated with each of legacy measures. Six-minute walk scores were most highly correlated with the PROMIS physical function domain scores (r=0.53) followed by the fatigue (r=-0.26), social (r=0.24) and to a lesser extent depression (r=-0.23) and anxiety (r=-0.22) domain scores. Percent predicted FEV1 score was significantly associated with PROMIS physical function scores (r=0.27). Conclusion This study provides support for the validity of the PROMIS measures in COPD patients.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionsupporting

confidence: 86%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Sensitivity to change as measured as standardized response means is comparable to other studies using the MYMOP [6],[14]. Patients in our study reported large effects (SRM > .80) on almost all MYMOP scales, reflecting the high proportion of patients also reporting a subjective improvement of their symptoms.…”

Section: Discussionsupporting

confidence: 85%

“…In 2010, the MYMOP was translated to a valid and change-sensitive Chinese version [10]. Studies evaluating the MYMOP have shown its good content validity [11], feasibility [12], and sensitivity to change [13],[14]. Although MYMOP has been mostly implemented in studies in the field of Complementary and Alternative Medicine (CAM), it is capable of measuring effects from a wide variety of health care interventions and is more sensitive to change than the SF-36 instrument [6].…”

Section: Introductionmentioning

confidence: 99%

A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP)

Hermann

Herrmann

Joos

2014

Health Qual Life Outcomes

View full text Add to dashboard Cite

BackgroundMeasure Yourself Medical Outcome Profile (MYMOP) is a patient-generated outcome instrument capable of measuring effects from a wide range of health care interventions. This paper reports the translation of this instrument into German (MYMOP-D) and the assessment of validity and sensitivity to change for the MYMOP-D. The instrument was piloted in a German primary care context.MethodsThe translation process was conducted according to international guidelines. Recruited patients of both general practitioners and non-medical Complementary and Alternative Medicine (CAM) practitioners (“Heilpraktiker”) in the German state of Baden-Wuerttemberg completed a questionnaire comprised of the MYMOP-D and the EQ-5D. Responses were analysed to assess construct validity. For assessing the instrument’s sensitivity to change, patients received the MYMOP-D again after four weeks at which point they were also asked for their subjective views on change of symptoms. Correlation between MYMOP-D and EQ-5D and sensitivity to change as gradient in score change and as standardized response mean (SRM) were calculated.Results476 patients from general practices and 91 patients of CAM practitioners were included. Construct validity of the MYMOP-D was given with a correlation of r = .47 with the EQ-5D. Sensitivity to change for subjective change of symptoms could only be analysed for improvement or no change of symptoms, as only 12 patients reported deterioration of symptoms. Results showed the expected smooth gradient with 2.2, 1.3, and 0.5 points of change for large, little improvement and no change, respectively. SRM for MYMOP-D Profile Score was 0.88.ConclusionsThe MYMOP-D shows excellent construct validity. It is able to detect changes when symptoms in patients improve or remain unchanged. Deterioration of symptoms could not be evaluated due to too few data. With its brevity and simplicity, it might be an important tool for enhancing patient-centred care in the German health care context.Electronic supplementary materialThe online version of this article (doi:10.1186/s12955-014-0112-5) contains supplementary material, which is available to authorized users.

show abstract

Naturopathic treatment of rotator cuff tendinitis among Canadian postal workers: A randomized controlled trial

Szczurko¹,

Cooley²,

Mills³

et al. 2009

Arthritis & Rheumatism

View full text Add to dashboard Cite

Objective. To explore the effectiveness of naturopathic care (NC) on rotator cuff tendinitis using a prospective randomized clinical trial design. Methods. Canadian postal workers with rotator cuff tendinitis for a duration of >6 weeks were randomized to receive NC (n ‫؍‬ 43) or standardized physical exercises (PEs; n ‫؍‬ 42) over 12 weeks. Participants in the NC group received dietary counseling, acupuncture, and Phlogenzym (2 tablets 3 times/day). The PE intervention group received passive, activeassisted, and active range of motion exercises and matched placebo. The primary outcome measure was the Shoulder Pain and Disability Index (SPADI), and secondary outcomes were the pain visual analog scale (VAS), Short Form 36 (SF-36), Measure Yourself Medical Outcomes Profile (MYMOP), and shoulder maximal range of motion. Participants and assessors were blinded to group and placebo allocation. Results. Seventy-seven participants (87%) completed >8 weeks of the trial. Final total SPADI scores decreased by 54.5% (P < 0.0001) in the NC group and by 18% (P ‫؍‬ 0.0241) in the PE group. Between-group differences in changes to SPADI scores showed statistically significant decreases in shoulder pain and disability in the NC group compared with the PE group (P < 0.0001). Significant differences between groups were also observed in the pain VAS, MYMOP, SF-36, and shoulder extension, flexion, and abduction, with the NC group showing superiority in each outcome. No serious adverse reactions were observed. Conclusion. NC and PE provided significant improvements, with greater improvement in shoulder function in the NC group compared with the PE group. Statistically significant improvements in quality of life measures were observed in the NC group as compared with the PE group.

show abstract

Untitled

Cited by 75 publications

References 9 publications

Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations

Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations

A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP)

Naturopathic treatment of rotator cuff tendinitis among Canadian postal workers: A randomized controlled trial

Contact Info

Product

Resources

About